methadone has been researched along with transforming growth factor beta in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, YH; Chen, KC; Chen, PS; Chen, SL; Hong, JS; Huang, SY; Lee, IH; Lee, SY; Lu, RB; Tzeng, NS; Wang, LJ; Wang, TY; Yang, YK | 1 |
| Aghadavod, E; Asemi, Z; Bahmani, F; Banafshe, HR; Ghaderi, A; Karimi, MA; Mansournia, MA; Mehrzad, F; Mirhosseini, N; Motmaen, M; Reiter, RJ | 1 |
2 trial(s) available for methadone and transforming growth factor beta
| Article | Year |
|---|---|
Low-dose memantine attenuated methadone dose in opioid-dependent patients: a 12-week double-blind randomized controlled trial.
Topics: Analgesics, Opioid; Brain-Derived Neurotrophic Factor; C-Reactive Protein; Dopamine Agents; Double-Blind Method; Drug Therapy, Combination; Humans; Interleukin-6; Interleukin-8; Memantine; Methadone; Opiate Substitution Treatment; Opioid-Related Disorders; Placebos; Transforming Growth Factor beta; Treatment Outcome; Tumor Necrosis Factor-alpha | 2015 |
The effects of melatonin supplementation on mental health, metabolic and genetic profiles in patients under methadone maintenance treatment.
Topics: Adult; Analgesics, Opioid; Antioxidants; Anxiety; Blood Glucose; C-Reactive Protein; Cholesterol, HDL; Cholesterol, LDL; Cholesterol, VLDL; Depression; Double-Blind Method; Gene Expression; Glutathione; Humans; Insulin Resistance; Interleukin-1; Male; Malondialdehyde; Melatonin; Mental Health; Methadone; Middle Aged; Nitric Oxide; Opiate Substitution Treatment; Opioid-Related Disorders; Penile Erection; PPAR gamma; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Sleep; Transforming Growth Factor beta; Triglycerides; Tumor Necrosis Factor-alpha | 2019 |